Kidney diseases are increasingly common today, primarily due to environmental factors, poor nutrition, physical inactivity, and chronic stress.

Among urological disorders, urolithiasis (kidney stone disease) ranks third in prevalence. This condition is characterized by the formation of stones in the kidneys, ureters, or bladder.

Urolithiasis has significant social implications, as approximately 55% of patients report a substantial decline in quality of life, especially during disease exacerbations. Additionally, the high recurrence rate of this condition underscores the necessity of continuous preventive measures.

During a scientific and practical conference, leading experts in national urology addressed pressing issues related to the diagnosis and treatment of urological diseases. The event gathered medical professionals from various specialties, including urologists, nephrologists, sexologists, and family doctors.

Valeriy Zaitsev, Professor, Doctor of Medical Sciences, delivered a presentation on modern principles of urolithiasis prevention. He provided a comprehensive analysis of the etiological factors and emphasized the role of lifestyle in preventing kidney stone disease. Special attention was given to the use of Nokamen, a contemporary formulation for managing urolithiasis.

Nokamen is a complex plant-mineral supplement containing components with diverse properties, including litholytic, anti-inflammatory, antioxidant, and nephroprotective effects. Thanks to its well-balanced combination of herbal ingredients, Nokamen exhibits a broad spectrum of pharmacological activity in inflammatory urinary tract diseases and serves as an ideal preventive solution for urolithiasis.

NOKAMEN – A Nephroprotective Solution with Broad Potential*.